Takeda Antitrust Trial Over Actos Generics Set For July
By Matthew Perlman · April 1, 2025, 9:10 PM EDT
A New York federal court refused a bid from Takeda Pharmaceuticals Co. to escape a long-running case accusing it of unlawfully delaying generic versions of its diabetes treatment Actos and scheduled...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login